AP111 Contemporary Issues and Emerging Concepts in Prostate Needle Biopsy Interpretation and Reporting: Diagnosis and Differential Diagnosis, Gleason Grading, and More

8:00–11:30 am
3.75 CME/SAM CREDITS

This course covers all the practical issues related to the interpretation of prostate biopsies in day-to-day practice:

Diagnosis of limited cancer and distinction from common benign mimickers
Diagnosis and clinical significance of “atypical” and high-grade prostatic intraepithelial neoplasia (HGPIN) diagnoses
Prostate cancers mimicking benign lesions
Contemporary Gleason grading scheme
Routine and new immunohistochemical markers
Reporting of prostate biopsy

Faculty will use numerous case images to illustrate the prototypic as well as uncommon microscopic features of prostate lesions. Following this session, participants may complete a related online self-assessment module, available at cap.org through October 26, 2011.

You will learn to:

Diagnose limited prostate cancer on needle biopsy based on the morphological features and immunohistochemical characteristics
Recognize the benign mimickers of cancer and cancer that mimics benign conditions
Describe emerging new concepts, such as the significance of high grade PIN, and new entities, such as intraductal cancer of the prostate, and their clinical significance
Apply the modified Gleason grading scheme
Produce a comprehensive, yet concise report of prostate biopsy

Faculty
Rajal B. Shah, MD, FCAP
Ming Zhou, MD, PhD, FCAP